RIGEL PHARMACEUTICALS INC (RIGL) Executive Compensation
RIGEL PHARMACEUTICALS INC (RIGL) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RIGL
CIK: 1034842
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerArusa Malik
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0000905148-26-004080 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0000905148-26-004079 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0000905148-26-004078 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0000905148-26-004077 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003612 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-088747 | View SEC Doc Filr Page |
| S-8 | 2026-08-04 | — | S-8 | 0001034842-26-000055 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001034842-26-000053 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001034842-26-000052 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | FORM 4 | 0000905148-26-003238 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-06-25 | 8-K | 0001034842-26-000045 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | FORM 4 | 0000905148-26-003076 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003039 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003040 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003038 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003037 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0000905148-26-003036 | View SEC Doc Filr Page |
| 144 | 2026-06-22 | — | 144 Filing | 0001959173-26-004799 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-11 | 8-K | 0001034842-26-000043 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0000905148-26-002811 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0000905148-26-002810 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0000905148-26-002809 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0000905148-26-002808 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0000905148-26-002807 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-26 | FORM 4 | 0000905148-26-002724 | View SEC Doc Filr Page |